SC

Sue Ann Costa Clemens

University of Oxford, Hospital Israelita Albert Einstein, Universidade Federal de São Paulo, Universidade Federal Fluminense, Instituto Carlos Chagas, Medical College of Pennsylvania Hospital

Research areas: Medicine · Infectious Diseases · Vaccine Coverage and Hesitancy · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies

ORCID iD 0000-0001-9576-0878
Follow

About

SUE ANN COSTA CLEMENS, MD, MSc, PhD, CORB, COMM, CBE
Professor in the Department of International Health at Johns Hopkins University, head of the Institute for Global Health at the University of Siena—where she is a professor of pediatric infectious diseases and directs the Master’s Program in Vaccinology and Drug Development—as well as a faculty member and international scientific coordinator at the Carlos Chagas Institute. She is a senior advisor to the Gates Foundation and a member of international scientific boards and committees, including the International Vaccine Institute, the GHIT Fund, VaxThera, Ourofino, and Clover Biopharmaceuticals. She was a full professor of global health and clinical development at the University of Oxford, where she created and directed the Oxford Latam Vaccines Group, and was a member of the WHO expert group on vaccine access and information (TAG-MI4A). In a career spanning more than 25 years, she has contributed to the development of over 20 globally licensed vaccines and medicines, including three COVID-19 vaccines as principal investigator. She was appointed Commander of the Order of the British Empire (CBE) by HM Queen Elizabeth II for services to public health and is also a Commander of the Federative Republic of Brazil in the Order of Rio Branco and the Order of Medical Merit.

Top 10% of Authors on SSRN by all-time downloads (date of assessment: March 3, 2023
SSRN's Top Ten list for: COVID-19 eJournal; paper: Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (date of assessment: August 3rd, 2023); http://dx.doi.org/10.2139/ssrn.3777268

Employment

  • University of Oxford Chair of Global Health and Clinical Development
    2023 - Present
  • World Health Organization Member of the Technical Advisory Group
    2023 - 2023
  • Hospital Israelita Albert Einstein Member of the International Hub
    2022 - Present
  • University of Oxford Visiting Professor in Global Health, Director of the Oxford Vaccine Group, Founder and Director of the Oxford LATAM Unit
    2021 - Present
  • Instituto Carlos Chagas Member of the Executive Board
    2020 - Present
  • Clover Biopharmaceuticals (China) Member of the Scientific Advisory Board
    2020 - Present
  • Gates Medical Research Institute Chair of the Covid 19 Scientific Committee
    2020 - 2023
  • CureVac (Germany) Member of the Scientific Advisory Board
    2020 - 2022
  • Bill & Melinda Gates Foundation Global Health Division Senior Advisor
    2012 - Present
  • University of Siena Head Institute for Global Health , Program Director of the Master Program in Vaccinology and Drug Development
    2008 - Present
  • GSK Biologicals VP and Head
    2001 - 2006
  • SmithKline Beecham Biologicals Associate Director
    1999 - 2001
  • GlaxoSmithKline USA Collegeville Manager Clinical R&D
    1997 - 1997
  • SmithKline Beecham Brazil Medical Manager
    1994 - 1997
  • Merck & Co , Pfizer Co- investigator
    1993 - 1994

Education

  • Universidade Federal de São Paulo Postgraduate Course for full Professorship in Pediatric Infectious Diseases
    2000 - 2006
  • Universidade Federal Fluminense Master Degree
    1995 - 1997
  • Medical College of Pennsylvania Hospital Postgraduation/ Fellow of the International Team of ECFMG Educational Commission for Foreign Medical Graduates
    1994 - 1995
  • Instituto de Pós-Graduacão Médica Carlos Chagas Postgraduate
    1993 - 1994
  • Policlinica Geral do Rio de Janeiro Medical Residency
    1992 - 1995
  • Fundação Tecnico Educação Souza Marques Escola de Medicina Souza Marques Medical Doctor
    1985 - 1991

Projects & Funding

Projects & funding information is unavailable.

Publications (116)